How the Cannabis Act Affects Research

Dr. Melanie Kelly will discuss drug development in the cannabis/cannabinoid space and in the development of scientific material for public dissemination and knowledge translation.

Sara Whynot, a longtime research employee at NSHA and Dalhousie, will speak about navigating Health Canada’s regulations pertaining to use of controlled substances in clinical and pre-clinical research.


Tuesday, November 27, 2018 - 12:00pm - 1:00pm

Event Type:


Target Audience:


Location Details:

Royal Bank Theatre, 1st Floor Halifax Infirmary, 1796 Summer St, Halifax NS